Prof. dr hab. Grzegorz Dubin
Protein Crystallography Research Group
Małopolska Center of Biotechnology
Jagiellonian University
Kraków, Poland
Prof. dr hab. Tad Holak
Faculty of Chemistry
University of Gdańsk
Gdańsk, Poland
Prof. dr hab. Jósef Dulak
Department of Medical Biotechnology
Faculty of Biochemistry, Biophysics and Biotechnology
Kraków, Poland
Prof. Nathanael Gray
Dana-Farber Cancer Institute
Boston, USA
Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School and Professor of Cancer Biology at Dana-Farber Cancer Institute. His work focuses on synthetic chemistry and novel small molecule inhibitors.
Prof. Laurent Meijer
ManRos Therapeutics
Perha Pharmaceuticals
Roscoff, France
One of the world’s leading experts in disease-relevant kinases and their pharmacological inhibitors. Dr. Meijer has generated more than 40 patents, published over 340 articles, edited 6 books and has been working with three Nobel Prize recipients. In 1985-86, with Edwin Krebs (Nobel Prize award 1992), he extensively characterized the M-phase specific Histone H1 kinase (which turned out to be CDK1/cyclin B). In the late ’80s, with Tim Hunt (Nobel Prize award 2001), he identified the CDK1 associated regulatory subunit as cyclin B. With Paul Greengard (Nobel Prize award 2000), he has been studying brain protein kinases and pharmacological inhibitors for three years (2001-2004) at the Rockefeller University (New York).
Prof. Jun Wang
School of Medicine and South China University of Technology (SCUT)
Guangzhou, China
Professor Wang has actively conducted research on anticancer nanomedicine carriers and tumor microenvironment, and has made innovative academic achievements as systematically revealing the effect of nano characteristics of nano drug carriers on the in vivo fate; proposed and developed a new idea of drug carrier material design for activation within the acidic environment of tumor, and comprehensively overcoming multiple barrier to its delivery in vivo.
Dr. Grzegorz Popowicz
The Bavarian NMR Center (BNMRZ)
Neuherberg, Germany
Group leader at The Bavarian NMR Center (BNMRZ), a joint research infrastructure of the Technical University of Munich (TUM) and the Helmholtz Center Munich (HMGU), with locations both at the Chemistry Department of TUM and the HMGU campus.
Prof. Asko Uri
Bioorganic Chemistry Department
University of Tartu
Tartu, Estonia
A leading scientist at the University of Tartu. Prof. Uri has been working in the field of protein kinase inhibition for more than 10 years. He has published various research papers and is an inventor for 3 pending patents.
Prof. Richard Engh
The Norwegian Structural Biology Centre, NorStruct
The Arctic University of Norway, UiT
Tromsø, Norway
Professor and Head of the Department of Chemistry of the Arctic University of Norway. Prof. Engh's research interests are related to enzyme-ligand interactions - especially protein kinases, drug design, and cheminformatics.
Dr. Ulli Rothweiler
The Norwegian Structural Biology Centre, NorStruct
The Arctic University of Norway, UiT
Tromsø, Norway
Researcher at the Department of Chemistry of the Arctic University of Norway.
